Treprostinil treatment for interstitial lung disease and asthma
AssigneeUnited Therapeutics Corporation
InventorsMichael Wade, Stuart Rich, Eugene Sullivan, Robert Roscigno, Roger Jeffs
Life of this patent
Estimating the term…
Abstract
The present invention describes methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of interstitial lung disease or asthma, or a condition, such as pulmonary fibrosis, associated with interstitial lung disease or a condition associated with asthma. The invention also relates to kits for treatment and/or prevention of such condition that include an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
Claims7
A method for treating a condition associated with an interstitial lung disease, comprising parenteral administration to a subject in need thereof an effective amount of Treprostinil, or a pharmaceutically acceptable salt thereof, wherein said condition is a pulmonary hypertension, which a complication of said interstitial lung disease.
Dependencies are inferred from the claim text.